Inogen reported $12M in Pre-Tax Profit for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Abbott ABT:US $ 2469M 317M
Abiomed ABMD:US $ -9.35M 82.84M
Accuray ARAY:US $ -10.69M 11.02M
Atricure ATRC:US $ -16.18M 0.7M
Becton, Dickinson and BDX:US $ 1023M 108M
Boston Scientific BSX:US $ 665M 93M
Cardiovascular Systems CSII:US $ -5.22M 2.63M
Genmark Diagnostics GNMK:US $ -3.7M 0.46M
Hill Rom HRC:US $ 116.6M 28.4M
Inogen INGN:US $ 12M 14.39M
Insulet PODD:US $ -28.4M 28.7M
Natus Medical BABY:US $ 12.92M 6.11M
Philips PHIA:NA € 523M 352M
Zimmer Biomet Holdings Inc ZBH:US $ 480.5M 53.3M